Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region

Lance Jennings, Qiu Sue Huang, Ian Barr, Ping Ing Lee, Woo Joo Kim, Philippe Buchy, Melvin Sanicas, Bruce A. Mungall, Jing Chen

Research output: Contribution to journalComment/debate

19 Citations (Scopus)

Abstract

Influenza control strategies focus on the use of trivalent influenza vaccines containing two influenza A virus subtypes and one of the two circulating influenza type B lineages (Yamagata or Victoria). Mismatches between the vaccine B lineage and the circulating lineage have been regularly documented in many countries, including those in the Asia-Pacific region. We conducted a literature review with the aim of understanding the relative circulation of influenza B viruses in Asia-Pacific countries. PubMed and Western Pacific Region Index Medicus were searched for relevant articles on influenza type B published since 1990 in English language for 15 Asia-Pacific countries. Gray literature was also accessed. From 4834 articles identified, 121 full-text articles were analyzed. Influenza was reported as an important cause of morbidity in the Asia-Pacific region, affecting all age groups. In all 15 countries, influenza B was identified and associated with between 0% and 92% of laboratory-confirmed influenza cases in any one season/year. Influenza type B appeared to cause more illness in children aged between 1 and 10 years than in other age groups. Epidemiological data for the two circulating influenza type B lineages remain limited in several countries in the Asia-Pacific, although the co-circulation of both lineages was seen in countries where strain surveillance data were available. Mismatches between circulating B lineages and vaccine strains were observed in all countries with available data. The data suggest that a shift from trivalent to quadrivalent seasonal influenza vaccines could provide additional benefits by providing broader protection.

Original languageEnglish
Pages (from-to)383-411
Number of pages29
JournalInfluenza and other Respiratory Viruses
Volume12
Issue number3
DOIs
Publication statusPublished - 2018 May 1

Fingerprint

Human Influenza
Epidemiology
Influenza Vaccines
Vaccines
Age Groups
Influenza B virus
Victoria
Influenza A virus
PubMed
MEDLINE
Language
Morbidity

Keywords

  • Asia-Pacific
  • epidemiology
  • influenza B
  • literature review
  • seasonality
  • vaccine mismatch

ASJC Scopus subject areas

  • Epidemiology
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region. / Jennings, Lance; Huang, Qiu Sue; Barr, Ian; Lee, Ping Ing; Kim, Woo Joo; Buchy, Philippe; Sanicas, Melvin; Mungall, Bruce A.; Chen, Jing.

In: Influenza and other Respiratory Viruses, Vol. 12, No. 3, 01.05.2018, p. 383-411.

Research output: Contribution to journalComment/debate

Jennings, L, Huang, QS, Barr, I, Lee, PI, Kim, WJ, Buchy, P, Sanicas, M, Mungall, BA & Chen, J 2018, 'Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region', Influenza and other Respiratory Viruses, vol. 12, no. 3, pp. 383-411. https://doi.org/10.1111/irv.12522
Jennings, Lance ; Huang, Qiu Sue ; Barr, Ian ; Lee, Ping Ing ; Kim, Woo Joo ; Buchy, Philippe ; Sanicas, Melvin ; Mungall, Bruce A. ; Chen, Jing. / Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region. In: Influenza and other Respiratory Viruses. 2018 ; Vol. 12, No. 3. pp. 383-411.
@article{859f443cbf6547b0b257e35090e269c9,
title = "Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region",
abstract = "Influenza control strategies focus on the use of trivalent influenza vaccines containing two influenza A virus subtypes and one of the two circulating influenza type B lineages (Yamagata or Victoria). Mismatches between the vaccine B lineage and the circulating lineage have been regularly documented in many countries, including those in the Asia-Pacific region. We conducted a literature review with the aim of understanding the relative circulation of influenza B viruses in Asia-Pacific countries. PubMed and Western Pacific Region Index Medicus were searched for relevant articles on influenza type B published since 1990 in English language for 15 Asia-Pacific countries. Gray literature was also accessed. From 4834 articles identified, 121 full-text articles were analyzed. Influenza was reported as an important cause of morbidity in the Asia-Pacific region, affecting all age groups. In all 15 countries, influenza B was identified and associated with between 0{\%} and 92{\%} of laboratory-confirmed influenza cases in any one season/year. Influenza type B appeared to cause more illness in children aged between 1 and 10 years than in other age groups. Epidemiological data for the two circulating influenza type B lineages remain limited in several countries in the Asia-Pacific, although the co-circulation of both lineages was seen in countries where strain surveillance data were available. Mismatches between circulating B lineages and vaccine strains were observed in all countries with available data. The data suggest that a shift from trivalent to quadrivalent seasonal influenza vaccines could provide additional benefits by providing broader protection.",
keywords = "Asia-Pacific, epidemiology, influenza B, literature review, seasonality, vaccine mismatch",
author = "Lance Jennings and Huang, {Qiu Sue} and Ian Barr and Lee, {Ping Ing} and Kim, {Woo Joo} and Philippe Buchy and Melvin Sanicas and Mungall, {Bruce A.} and Jing Chen",
year = "2018",
month = "5",
day = "1",
doi = "10.1111/irv.12522",
language = "English",
volume = "12",
pages = "383--411",
journal = "Influenza and other Respiratory Viruses",
issn = "1750-2640",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region

AU - Jennings, Lance

AU - Huang, Qiu Sue

AU - Barr, Ian

AU - Lee, Ping Ing

AU - Kim, Woo Joo

AU - Buchy, Philippe

AU - Sanicas, Melvin

AU - Mungall, Bruce A.

AU - Chen, Jing

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Influenza control strategies focus on the use of trivalent influenza vaccines containing two influenza A virus subtypes and one of the two circulating influenza type B lineages (Yamagata or Victoria). Mismatches between the vaccine B lineage and the circulating lineage have been regularly documented in many countries, including those in the Asia-Pacific region. We conducted a literature review with the aim of understanding the relative circulation of influenza B viruses in Asia-Pacific countries. PubMed and Western Pacific Region Index Medicus were searched for relevant articles on influenza type B published since 1990 in English language for 15 Asia-Pacific countries. Gray literature was also accessed. From 4834 articles identified, 121 full-text articles were analyzed. Influenza was reported as an important cause of morbidity in the Asia-Pacific region, affecting all age groups. In all 15 countries, influenza B was identified and associated with between 0% and 92% of laboratory-confirmed influenza cases in any one season/year. Influenza type B appeared to cause more illness in children aged between 1 and 10 years than in other age groups. Epidemiological data for the two circulating influenza type B lineages remain limited in several countries in the Asia-Pacific, although the co-circulation of both lineages was seen in countries where strain surveillance data were available. Mismatches between circulating B lineages and vaccine strains were observed in all countries with available data. The data suggest that a shift from trivalent to quadrivalent seasonal influenza vaccines could provide additional benefits by providing broader protection.

AB - Influenza control strategies focus on the use of trivalent influenza vaccines containing two influenza A virus subtypes and one of the two circulating influenza type B lineages (Yamagata or Victoria). Mismatches between the vaccine B lineage and the circulating lineage have been regularly documented in many countries, including those in the Asia-Pacific region. We conducted a literature review with the aim of understanding the relative circulation of influenza B viruses in Asia-Pacific countries. PubMed and Western Pacific Region Index Medicus were searched for relevant articles on influenza type B published since 1990 in English language for 15 Asia-Pacific countries. Gray literature was also accessed. From 4834 articles identified, 121 full-text articles were analyzed. Influenza was reported as an important cause of morbidity in the Asia-Pacific region, affecting all age groups. In all 15 countries, influenza B was identified and associated with between 0% and 92% of laboratory-confirmed influenza cases in any one season/year. Influenza type B appeared to cause more illness in children aged between 1 and 10 years than in other age groups. Epidemiological data for the two circulating influenza type B lineages remain limited in several countries in the Asia-Pacific, although the co-circulation of both lineages was seen in countries where strain surveillance data were available. Mismatches between circulating B lineages and vaccine strains were observed in all countries with available data. The data suggest that a shift from trivalent to quadrivalent seasonal influenza vaccines could provide additional benefits by providing broader protection.

KW - Asia-Pacific

KW - epidemiology

KW - influenza B

KW - literature review

KW - seasonality

KW - vaccine mismatch

UR - http://www.scopus.com/inward/record.url?scp=85043345472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043345472&partnerID=8YFLogxK

U2 - 10.1111/irv.12522

DO - 10.1111/irv.12522

M3 - Comment/debate

C2 - 29127742

AN - SCOPUS:85043345472

VL - 12

SP - 383

EP - 411

JO - Influenza and other Respiratory Viruses

JF - Influenza and other Respiratory Viruses

SN - 1750-2640

IS - 3

ER -